Claversal

Claversal is a rectal formulation of mesalazine, used for managing inflammatory conditions in the lower gastrointestinal tract. This medication helps reduce inflammation and maintain remission. Ideal for targeted relief, Claversal is manufactured by Faes Farma, S.A.

Claversal, containing mesalazine, is primarily used for the treatment of inflammatory bowel diseases, particularly those affecting the rectum and lower colon. It is often prescribed to manage symptoms such as rectal bleeding, diarrhea, and abdominal pain. Mesalazine works by reducing inflammation in the digestive tract, helping to alleviate discomfort and promote healing. This medication is commonly used in the maintenance of remission in conditions like ulcerative colitis.

Claversal may cause common side effects such as mild abdominal cramps, diarrhea, or headache. Some users might experience rectal irritation or discomfort. These effects are generally temporary and subside as the body adjusts to the medication. If any severe or persistent side effects occur, it is advisable to consult a healthcare professional.

Claversal should be used with caution in individuals with known allergies to mesalazine or related compounds. It is important to follow the prescribed dosage and administration instructions to minimize the risk of side effects. Patients with kidney or liver conditions should discuss their medical history with a healthcare provider before using this medication. Always store Claversal in a cool, dry place away from direct sunlight.

Claversal may interact with certain medications, including nonsteroidal anti-inflammatory drugs (NSAIDs) and other bowel preparations. Alcohol consumption should be avoided as it may exacerbate gastrointestinal side effects. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always consult a healthcare professional before starting or stopping any medication.